ThursdayOct 12, 2023 10:30 am

PaxMedica Inc. (NASDAQ: PXMD) CEO Presents ASD Pipeline and Corporate Presentation at H.C. Wainwright 25th Annual Global Investment Conference

Howard Weisman presented PaxMedica’s goals and plans to investors at the H.C. Wainwright 25th Annual Global Investment Conference on September 12, 2023 The presentation defined the company’s intention to generate significant funding for its ASD program by first gaining approval for suramin sodium in the treatment of a rare and deadly infection using the same drug The global ASD treatment market was valued at $2.02 billion and is expected to reach $3.28 billion by 2030 Howard Weisman, CEO of PaxMedica (NASDAQ: PXMD), a clinical-stage biopharmaceutical company focusing on the development of novel anti-purinergic therapies (“APTs”) for the treatment of Autism Spectrum…

Continue Reading

WednesdayOct 11, 2023 2:37 pm

Syndromic Testing Could Transform Infectious Disease Diagnosis

The coronavirus pandemic put a spotlight on the potential danger of infectious diseases and has helped spur research to develop faster and more efficient means of diagnosing infectious diseases. Early diagnosis of infectious diseases is critical to developing proper treatment and prevention protocols. It can save a patient’s life and prevent them from spreading the infectious disease to other people while they are still undiagnosed, reducing the likelihood of outbreaks occurring and crippling healthcare systems. With the demand for quick and accurate infectious disease diagnosis rising by the day, researchers are constantly working to develop novel techniques such as syndromic…

Continue Reading

TuesdayOct 10, 2023 3:27 pm

Patients with Metastatic Solid Tumors Have Better Outcomes After Prophylactic Radiation, Study Finds

A new study has revealed that prophylactic radiation may be able to improve treatment outcomes for patients with solid metastatic tumors. Prophylactic cranial radiation (PCR) or prophylactic cranial irradiation (PCI) is a type of radiation therapy used to kill cancer cells from cancers such as small-cell lung cancer that have spread to the brain and prevent further invasion of brain tissue. According to a paper published in the “Journal of Clinical Oncology,” applying prophylactic radiation to asymptomatic bone metastases in patients diagnosed with solid tumor malignancies can improve patient outcomes. During phase 2 trials, patients who received prophylactic radiation reported…

Continue Reading

MondayOct 09, 2023 10:28 am

Five Must-Have Design Features for e-Commerce Sites

With a share of close to 19% of total retail sales, e-commerce plays an increasingly large role in the American retail market. Millions of online stores are fighting to attract customers, and around 80% to 90% of them fail before they can build a market presence. Although this extremely high failure rate is caused by factors such as poor marketing, limited search visibility and intense competition, poor design can also lower your website’s chances of success. To stand out from the more than 26.5 million e-commerce websites fighting to succeed in the online sales segment, you will have to implement…

Continue Reading

FridayOct 06, 2023 11:52 am

First Time Ever: Researchers Eliminate Brain Cancer Using Quantum Therapy

University of Nottingham scientists have developed a new quantum therapeutic approach to treating cancer that could treat one of the most aggressive types of brain cancer, glioblastoma. The researchers created a new spray treatment capable of treating glioblastoma through quantum signaling, making their treatment the first-ever, quantum-therapy-based treatment. This unique treatment works by changing neural cells at a quantum level via bio-nanoantennas, nano-particles of gold coated in redox-active molecules. According to the researchers, the novel treatment involves spraying glioblastoma tumor sites with bio-nanoantennae followed by the application of an electric field. University of Nottingham research fellow and study coauthor Frannkie…

Continue Reading

ThursdayOct 05, 2023 12:38 pm

Researchers Find Psoriasis Increases Risk of Heart Disease

Researchers have observed coronary microvascular dysfunction in a good number of patients with psoriasis. This is despite the fact that most of them hadn’t presented with any symptoms of cardiovascular illness. For their study, the researchers recruited 503 individuals who had been diagnosed with psoriasis but had not been diagnosed with cardiovascular disease. Prior research has demonstrated that individuals with severe psoriasis have heightened cardiovascular mortality and morbidity. Despite this, there’s been limited studies on the mechanisms underlying the heightened risk. The researchers were focused on learning more about the link between psoriasis and heart disease, centering on coronary blood…

Continue Reading

WednesdayOct 04, 2023 3:32 pm

New Prediction Model Could Slash Unnecessary Pancreatic Cancer Biopsies

Researchers have developed a new prediction model capable of “reliably detecting” pancreatic cancer in its early stages. The prediction model leverages regularly measured biomarkers in the blood to sharpen diagnostic processes for pancreatic cancer and reduce the need for unnecessary biopsy procedures by 6%. Pancreatic cancer is difficult to diagnose in its early stages because the pancreas is generally hidden by other organs and is located deep in the abdomen. Furthermore, pancreatic cancer often displays no physical symptoms until the cancer has metastasized to other organs, which makes the condition easy to miss during physical exams or through analyzing symptoms.…

Continue Reading

WednesdayOct 04, 2023 9:45 am

Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Secures $1.33 Million from Registered Direct Offering to Boost Commercial Development

Scinai Immunotherapeutics recently announced the closing of a registered direct offering, raising $1.33 million in gross proceeds The company intends to use the net proceed from the offering for, among others, research and development On its R&D agenda is the development and commercialization of novel innovative NanoAbs targeting a wide range of diseases with known and validated antibody drug targets This strategic approach is expected to shorten development timelines, reduce the budgetary requirements, and increase probability of drug approval The company has also expanded into the CDMO business to plug an existing gap in the market, raising recurring revenue as…

Continue Reading

TuesdayOct 03, 2023 1:51 pm

TikTok Hit as Indonesia Announces e-Commerce Transaction Ban on Social Media

Indonesian authorities dealt a major blow to TikTok’s expansion plans after they announced a national ban on virtual transactions on social media platforms. The social media platform TikTok has been working to accelerate e-commerce transactions in Indonesia, its largest market in Southeast Asia, as it fields increased scrutiny in other markets. However, the country’s government seems to have pulled the rug out from under TikTok’s feet. According to the government, the ban on social media e-commerce transactions is meant to protect offline marketplaces and merchants from the predatory pricing models on social media platforms that often outprice and threaten small…

Continue Reading

MondayOct 02, 2023 11:42 am

Novel Type of Immunotherapy Exhibits Efficacy Against Brain Tumors in Mouse Models

A multi-institutional team of researchers has developed a novel type of cellular immunotherapy that has proven its therapeutic effectiveness in mouse models. Comprised of  a researcher from the German Cancer Research Center and a University Medical Center Mannheim physician, the team used NLGN4X-specific T cells to successfully kill brain tumor cells from mice. NLGN4X (Neuroligin4X) is a protein that is involved in protein formation, and it occurs in large amounts in glioblastoma tumor cells even though they are barely present in healthy brain tissue. Glioblastoma is a type of brain cancer that originates in the nerve cell astrocytes within the…

Continue Reading

Official NewsWire Relationships

BIO Informa DGE Dynamic Global Events DTC Healthcare Conference Kiasco Reasearch Nexus Conferences Octane

BioMedWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000